REFERENCES
- Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K. The Eighth Frederick H Verhoeff Lecture. Behcet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979; 77: 225–279, [PUBMED], [INFOTRIEVE]
- Michelson J B, Chisari F V. Behcet's disease. Surv Ophthalmol. 1982; 26: 190–203, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Matsuo T, Sato Y, Shiraga F, Shiragami C, Tsuchida Y. Choroidal abnormalities in Behcet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology 1999; 106: 295–300, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Matsuo T, Itami M, Nakagawa H, Nagayama M. The incidence and pathology of conjunctival ulceration in Behcet's syndrome. Br J Ophthalmol. 2002; 86: 140–143, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078–1080
- Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y. Prognostic factors of vision in patients with Behcet disease. Ophthalmology 1995; 102: 317–321, [PUBMED], [INFOTRIEVE], [CSA]
- Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. Ophthalmology 1997; 104: 701–705, [PUBMED], [INFOTRIEVE], [CSA]
- Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003; 82: 60–76, [CROSSREF], [CSA]
- Yamamoto S, Toyokawa H, Matsubara J, Yanai H, Inaba Y, Nakae K, Ono M. A nation-wide survey of Behcet's disease in Japan. I. Epidemiological study. Jpn J Ophthalmol. 1974; 18: 282–290
- Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiological features and visual prognosis of Behcet's disease. Jpn J Ophthalmol. 1999; 43: 312–317, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Matsuo T, Takahashi M, Inoue Y, Egi K, Kuwata Y, Yamaoka A. Ocular attacks after phacoemulsification and intraocular lens implantation in patients with Behcet disease. Ophthalmologica. 2001; 215: 179–182, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Benezra D, Cohen E. Treatment and visual prognosis in Behcet's disease. Br J Ophthalmol. 1986; 70: 589–592, [PUBMED], [INFOTRIEVE]
- Toker E, Kazokoglu H, Acar N. High dose intravenous steroid therapy for severe posterior segment uveitis in Behcet's disease. Br J Ophthalmol. 2002; 86: 521–523, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nussenblatt R B, Palestine A G, Chan C C, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Behcet's disease. Arthritis Rheum. 1985; 28: 671–679, [PUBMED], [INFOTRIEVE]
- Whitcup S M, Salvo E C, jr, Nussenblatt R B. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease. Am J Ophthalmol. 1994; 118: 39–45, [PUBMED], [INFOTRIEVE], [CSA]
- Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, Senocak M, Yazici H. Azathioprine in Behcet's syndrome. Arthritis Rheum. 1997; 40: 769–774, [PUBMED], [INFOTRIEVE]
- Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, Basaran E. Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol. 2002; 138: 467–471, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Masuda H. Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy. Ophthalmology 1999; 106: 586–589, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]